ORIENTBIO, Inc. (002630) Financial Statements

― Followers

ORIENTBIO, Inc. Financial Overview

ORIENTBIO, Inc.'s market cap is currently ₩54.12B. The company's EPS TTM is ₩-1.88; its P/E ratio is -485.64; ORIENTBIO, Inc. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₩ 29.75B	₩ 29.40B	₩ 28.01B	₩ 28.82B	₩ 26.28B
Gross Profit	₩ 3.96B	₩ 7.20B	₩ 9.58B	₩ 9.82B	₩ 9.01B
Operating Income	₩ -4.44B	₩ -3.08B	₩ -645.95M	₩ 1.45B	₩ -3.78B
EBITDA	₩ -2.24B	₩ -11.02B	₩ 15.67B	₩ -9.25B	₩ 997.25M
Net Income	₩ -4.57B	₩ -13.19B	₩ 12.87B	₩ -12.42B	₩ 34.20B
Balance Sheet
Cash & Short-Term Investments	₩ 32.77B	₩ 32.53B	₩ 41.23B	₩ 35.47B	₩ 59.04B
Total Assets	₩ 81.62B	₩ 84.78B	₩ 96.99B	₩ 81.05B	₩ 104.95B
Total Debt	₩ 1.94B	₩ 2.62B	₩ 3.04B	₩ 847.75M	₩ 7.40B
Net Debt	₩ -3.90B	₩ -3.91B	₩ -3.07B	₩ -5.09B	₩ -22.60B
Total Liabilities	₩ 13.07B	₩ 12.94B	₩ 11.89B	₩ 9.66B	₩ 21.76B
Stockholders' Equity	₩ 68.54B	₩ 71.85B	₩ 85.10B	₩ 71.39B	₩ 83.19B
Cash Flow
Free Cash Flow	₩ 547.86M	₩ -4.04B	₩ 2.83B	₩ 674.30M	₩ 140.53M
Operating Cash Flow	₩ 2.60B	₩ 752.29M	₩ 3.76B	₩ 1.16B	₩ 2.35B
Investing Cash Flow	₩ -2.62B	₩ 315.65M	₩ -3.12B	₩ -20.66B	₩ 16.77B
Financing Cash Flow	₩ -688.56M	₩ -839.60M	₩ -570.35M	₩ -6.79B	₩ -1.13B

Currency in KRW

ORIENTBIO, Inc. Earnings and Revenue History

Income Statement >

ORIENTBIO, Inc. Debt to Assets

Balance Sheet >

ORIENTBIO, Inc. Cash Flow

Cash Flow >

ORIENTBIO, Inc. Forecast EPS vs Actual EPS

Earnings >